Suchergebnisse - "1748-6963" OR "1743-5889"

PubPharm (35)

1

Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine

enthalten in: Nanomedicine (London, England) | 2023

von Dias Assis, B. | Gomes, I. | de Castro, J. | +12

2

Emerging trends and promises of nanoemulsions in therapeutics of infectious diseases

enthalten in: Nanomedicine (London, England) | 2022

von Juneja, M. | Suthar, T. | Pardhi, V. | +2

3

Nanotechnology-based therapeutics for targeting inflammatory lung diseases

enthalten in: Nanomedicine (London, England) | 2022

von Loo, C. | Lee, W.

4

The role of nanomedicine in COVID-19 therapeutics

enthalten in: Nanomedicine (London, England) | 2022

von Sharma, S.

5

Emerging trends and promises of nanoemulsions in therapeutics of infectious diseases

enthalten in: Nanomedicine | 2022

von Juneja, M. | Suthar, T. | Pardhi, V. | +2

6

Nanotechnology-based therapeutics for targeting inflammatory lung diseases

enthalten in: Nanomedicine | 2022

von Loo, C. | Lee, W.

7

The role of nanomedicine in COVID-19 therapeutics

enthalten in: Nanomedicine | 2022

von Sharma, S.

8

Mucoadhesive nanoformulations and their potential for combating COVID-19

enthalten in: Nanomedicine (London, England) | 2021

von Prasher, P. | Sharma, M.

9

Nano-carriers of COVID-19 vaccines : the main pillars of efficacy

enthalten in: Nanomedicine (London, England) | 2021

von Constantin, C. | Pisani, A. | Bardi, G. | +1

10

Carbon nanomaterials as promising substrates in the design of sensors for SARS-CoV-2 and new emerging viral infections

enthalten in: Nanomedicine (London, England) | 2021

von Abbaszadeh, S. | Nikaeen, G. | Yousefinejad, S.